Research & KnowledgeEvent: September 5, 2026
Regenerative Medicine Solutions published a study in Science by A. J. Wesolowski et al. (2026) showing that mouse tumors release the enzyme peroxiredoxin 1 (PRDX1) into the interstitial fluid to remove H2O2 near T cells, which weakens T cell receptor signaling.
Published
Signal category
Research & Knowledge
Quote
“On page 1036 of the recent SCIENCE , Wesolowski et al. (2026) report that mouse tumors release the enzyme peroxiredoxin 1 (PRDX1) into the interstitial fluid. PRDX1 removes H2O2 near T cells, which weakens T cell receptor signaling.”
— Miguel Bronchud|Regenerative Medicine Solutions team
Company
- Industry
- Hospitals
- Location
- Barcelona, ES
- Company size
- 2 employees